Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Lung Cancer
Interventions
PROCEDURE

positron emission tomography

PROCEDURE

radionuclide imaging

RADIATION

fludeoxyglucose F 18

Trial Locations (23)

10021

Memorial Sloan-Kettering Cancer Center, New York

15224

Western Pennsylvania Cancer Institute, Pittsburgh

16105

Jameson Memorial Hospital, New Castle

27710

Duke Comprehensive Cancer Center, Durham

33756

Morton Plant Mease Health Care, Clearwater

48073

William Beaumont Hospital, Royal Oak

60068

Lutheran General Hospital, Park Ridge

63110

Barnes-Jewish Hospital, St Louis

84143

Latter Day Saints Hospital, Salt Lake City

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

33805-4500

Lakeland Regional Medical Center, Lakeland

60637-1470

University of Chicago Cancer Research Center, Chicago

46202-5289

Indiana University Cancer Center, Indianapolis

52242-1009

Holden Comprehensive Cancer Center, Iowa City

52246-2208

Veterans Affairs Medical Center - Iowa City, Iowa City

21201-1590

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

02114

Massachusetts General Hospital Cancer Center, Boston

10029-6574

Mount Sinai School of Medicine, New York

15601-2282

Westmoreland Hospital, Greensburg

15212-4772

Allegheny General Hospital, Pittsburgh

29425-0721

Medical University of South Carolina, Charleston

23298-0037

Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00004138 - Positron Emission Tomography for Detecting Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter